19 March 2026

Lupus Pharmaceuticals

More evidence for obinutuzumab in lupus patients

19 March 2026

Biologics Psoriatic Athritis

Bimekizumab and risankizumab go head-to-head

19 March 2026

Arthritis Paediatrics

Hidden arthritis crisis hurting Aussie kids

19 March 2026

Rheumatology

SA election spotlights rheumatology shortfall

19 March 2026

FDA Psoriatic Athritis

New oral option for psoriatic arthritis wins FDA nod

5 March 2026

Public Health Vaccination

Preparing for this year’s flu season

5 March 2026

Pharmaceuticals Plaque psoriasis

Bimekizumab still superior at three years

5 March 2026

Biologics Lupus

Real-world lupus study shows rapid response to anifrolumab

5 March 2026

ACR EULAR Rheumatoid Arthritis

Pred habit not forever in early RA

5 March 2026

Gout Rheumatoid Arthritis

RA and gout: no longer ships in the night?

19 February 2026

Exercise Osteoarthritis Rheumatology

Exercise benefits in osteoarthritis ‘minimal and short-lived’

19 February 2026

Immunology Lupus

CAR-T paper takes it up a notch

19 February 2026

Gastroenterology Pharmaceuticals

PPI use not linked to stomach cancer, new study finds

19 February 2026

giant cell arteritis Research Rheumatology

The unseen burden of giant cell arteritis

19 February 2026

AI Comment Technology

A comprehensive guide to AI in healthcare

19 February 2026

Biologics Clinical research Psoriasis

Adalimumab proves durable in practice